高危肺栓塞VA-ECMO支持下早期机械再灌注的多中心国际队列研究
该回顾性国际队列纳入39个ECMO中心2014至2024年因高危肺栓塞接受VA-ECMO的成人患者492例,其中28%接受早期机械再灌注。倾向匹配后每组137例,早期机械再灌注组90天死亡率为32%,单纯ECMO组为39%(HR 0.68,95%CI 0.45-1.03;结论认为早期机械再灌注未显著降低90天死亡率或ECMO时长。
要点
- 高危肺栓塞VA-ECMO患者中早期机械再灌注与90天死亡率降低无显著关联。
- 未接受过溶栓的患者中,早期机械再灌注与ECMO撤机率提高相关。
- 两组出血发生率均为50%,无显著差异。
核心结论
- 在高危肺栓塞接受VA-ECMO的患者中,早期机械再灌注治疗与90天死亡率降低或ECMO时长缩短无关。
- 研究结果可能支持以初始单纯ECMO支持为主的分步、个体化策略,但不能排除特定患者可从早期机械再灌注中获益。
研究设计与样本
- 回顾性国际多中心队列研究,纳入39个ECMO中心2014至2024年因高危肺栓塞接受VA-ECMO的成人患者492例。
- 早期机械再灌注定义为ECMO启动后48小时内行导管定向治疗或外科取栓。
- 排除ECMO启动后12小时内死亡或接受延迟再灌注的患者。
- 主要结局为90天死亡率,采用倾向匹配组间比较,匹配后每组137例。
主要发现
- 492例患者中位年龄53岁,69%发生心脏骤停,28%接受早期机械再灌注。
- 总体ECMO时长和撤机率相似。
- 出血发生率为50%,两组间无显著差异。
关键数值与推荐
- 早期机械再灌注定义:ECMO启动后48小时内行导管定向治疗或外科取栓。
- 出血发生率50%,组间无显著差异。
临床怎么用
- 对于高危肺栓塞启动VA-ECMO的患者,可考虑先以单纯ECMO支持为主,再个体化评估是否需要早期机械再灌注。
- 对于未接受溶栓的患者,早期机械再灌注可能有助于ECMO撤机,但需结合整体临床情况权衡。
- 鉴于出血发生率达50%,决策时应充分评估出血风险。
局限性
- 本研究为回顾性设计,存在选择偏倚和混杂可能。
- 研究结果不能排除特定患者从早期机械再灌注中获益的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore how early mechanical reperfusion impacts outcomes in high-risk pulmonary embolism (PE) patients supported by venoarterial extracorporeal membrane oxygenation (VA-ECMO). METHODS: This retrospective international study included adult patients treated with VA-ECMO for high-risk PE at 39 ECMO centers (2014-2024). Early mechanical reperfusion was defined as catheter-directed therapy or surgical embolectomy within 48 hours of ECMO initiation. Patients dying within 12 hours or receiving delayed reperfusion were excluded. The primary outcome was 90-day mortality, assessed using propensity-matched groups. MEASUREMENTS AND MAIN RESULTS: Among 492 patients on VA-ECMO (median age, 53 years), 69% had cardiac arrest, and 28% received early mechanical reperfusion. After propensity matching, 137 patients were compared in each group. Ninety-day mortality was 32% with early mechanical reperfusion on ECMO versus 39% with ECMO stand-alone (HR, 0.68 [95% CI, 0.45-1.03]; P = .07). Overall, ECMO duration and weaning rates were similar; however, early mechanical reperfusion improved ECMO weaning in patients without prior thrombolysis (subdistribution HR, 1.56 [95% CI, 1.03-2.36]; P = .04). Bleeding occurred in 50% of patients, with no significant difference between groups. CONCLUSIONS: In this large international cohort of patients with high-risk PE on VA-ECMO, early mechanical reperfusion therapy was not associated with a reduction in 90-day mortality or ECMO duration. These findings may support a stepwise, individualized approach favoring initial ECMO stand-alone support, although a certain clinical benefit from early mechanical reperfusion in selected patients cannot be excluded.
引用
- Levy, Petit, Assouline, et al. Early mechanical reperfusion in high-risk pulmonary embolism supported by venoarterial extracorporeal membrane oxygenation: a multicenter international cohort study. Am J Respir Crit Care Med. 2026. PMID: 41738098. doi:10.1093/ajrccm/aamaf116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。